The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

Share Price Information for Walker Crips (WCW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.50
Bid: 22.00
Ask: 23.00
Change: 0.00 (0.00%)
Spread: 1.00 (4.545%)
Open: 22.50
High: 22.50
Low: 22.00
Prev. Close: 22.50
WCW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Fund Management Contract

15 Mar 2017 07:00

RNS Number : 4798Z
Walker Crips Group plc
15 March 2017
 

15 March 2017

 

WALKER CRIPS GROUP PLC

("Walker Crips" or the "Company")

 

Sale of Fund Management Contract

 

This announcement contains information which prior to its disclosure was inside information for the purposes of the Market Abuse Regulation.

 

Walker Crips, the financial services group, announces it has entered into an agreement relating to the sale and transfer of its fund management contract (the "Transfer") in connection with the TB Walker Crips Corporate Bond Fund (the "Fund") to Smith & Williamson Investment Management LLP ("SWIM LLP").

As part of the Company's continued focus on integrated wealth management since the sale of its fund management related activities in 2012, the Board of Walker Crips has concluded that management of this Fund is no longer a core activity and is therefore being transferred to a fund manager which has the requisite resource, scale and track record to continue serving the Fund's investors well. As a result of the Transfer, on Completion the Fund will be renamed TB Riding House Street Fixed Interest Fund.

As at 28 February 2017, SWIM LLP managed some £1.3 billion in its dedicated funds business across a number of investment strategies.

FCA approval in connection with the Transfer has been received and completion shall occur 5 days following written notification being sent to underlying holders of the Fund ("Completion") which is expected to be posted later today. Accordingly, Completion is anticipated on Tuesday 21st March 2017.

 

For further information please contact:

Rodney FitzGerald, CEO

Walker Crips Group plc

+44 (0) 20 3100 8000

Rishi Zaveri

Cantor Fitzgerald Europe

+44 (0) 20 7894 7667

Media enquiries:

Geri Jacks

Walker Crips Group plcwww.wcgplc.co.uk

+44 (0) 20 3100 8000

 

Notes:

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

Forward-Looking Statements

This Announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's current expectations and projections about future events. These statements, which sometimes use words such has "aim, "anticipate", "believe", "intend", "plan", "estimate", "expect" and words of a similar meaning, reflect the directors' beliefs and expectations and involve a number of risks, uncertainties and assumptions that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Statements contained in this Announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this Announcement is subject to change without notice and, except as required by applicable law, neither the Company, nor any member of its group, its Directors or its Financial Adviser assumes any responsibility or obligation to update publicly or review any of the forward-looking statements contained therein. Investors should not place undue reliance on forward-looking statements, which speak only as of the date of this Announcement. No statement in this Announcement is or is intended to be a profit forecast or to imply that the earnings of the Company for the current or future financial years will necessarily match or exceed the historical or published earnings of the Company.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRJIMPTMBABBFR
Date   Source Headline
29th May 201912:01 pmRNSDirector/PDMR Shareholding
21st May 20195:15 pmRNSDirector/PDMR Shareholding
8th May 201911:30 amRNSDirector/PDMR Shareholding
27th Mar 20196:30 pmRNSDirector/PDMR Shareholding
13th Mar 20195:53 pmRNSReplacement Director/PDMR Shareholding
13th Mar 201912:53 pmRNSDirector/PDMR Shareholding
7th Mar 20194:52 pmRNSDirector/PDMR Shareholding
4th Mar 20198:44 amRNSDirector/PDMR Shareholding
1st Mar 20193:56 pmRNSDirector/PDMR Shareholding
26th Feb 20194:00 pmRNSTrading Update
12th Feb 20194:56 pmRNSDirector / PDMR Shareholdings
30th Jan 20197:00 amRNSBoard changes
17th Dec 201812:00 pmRNSDirector/PDMR Shareholding
27th Nov 20188:36 amRNSHalf-year Report - Replacement
27th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
29th Oct 201811:25 amRNSDirector/PDMR Shareholding
11th Oct 20182:53 pmRNSDirector/PDMR Shareholding
20th Sep 201811:10 amRNSDirector/PDMR Shareholding
14th Sep 20185:24 pmRNSDirector/PDMR Shareholding
5th Sep 20184:33 pmRNSResult of AGM
31st Jul 20184:08 pmRNSFinal Results
8th Jun 20183:28 pmRNSDirector/PDMR Shareholding
25th May 20187:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20188:20 amRNSHolding(s) in Company
18th Apr 20185:34 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHolding(s) in Company
6th Mar 20185:36 pmRNSHolding(s) in Company
19th Feb 20183:30 pmRNSDirector/PDMR Shareholding
9th Feb 20184:55 pmRNSDirectorate Change
4th Jan 201810:10 amRNSDirector/PDMR Shareholding
21st Dec 201710:10 amRNSDirector/PDMR Shareholding
13th Dec 201712:31 pmRNSHolding(s) in Company
13th Dec 201712:30 pmRNSDirector / PDMR Shareholdings
11th Dec 20178:24 amRNSDirector/PDMR Shareholding
1st Dec 20175:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20177:00 amRNSHalf-year Report
13th Oct 20177:00 amRNSIssue of Equity and Total Voting Rights
6th Sep 20174:02 pmRNSResult of AGM
31st Aug 20177:00 amRNSBoard changes
18th Jul 20177:00 amRNSAnnual Financial Results
22nd May 20171:41 pmRNSDirector/PDMR Shareholding
12th May 20177:00 amRNSIssue of Equity and Total Voting Rights
24th Mar 20175:09 pmRNSDirectorate Change
15th Mar 20177:00 amRNSSale of Fund Management Contract
9th Mar 20175:53 pmRNSHolding(s) in Company
9th Mar 20175:52 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSIssue of Equity and Total Voting Rights
3rd Mar 20173:13 pmRNSForm 8.3 - Clinical Computing
3rd Mar 20173:11 pmRNSForm 8.3 - Clinical Computing re Ian Amiee
21st Dec 201612:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.